Literature DB >> 34269332

Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019.

Jing Liu1,2, Xiang Bu3, Linyan Wei1,2, Xiqiang Wang1,2, Lulu Lai4, Caijuan Dong1,2, Aiqun Ma1,2, Tingzhong Wang1,2.   

Abstract

BACKGROUND: Hypertension grows into a serious public health problem among young adults, linking to a set of life-threatening cardiovascular diseases (CVDs). Young adults are not well represented in current knowledge about the CVDs burden attributable to hypertension.
METHODS: In this analysis of data from the GBD (Global Burden of Disease) study 2019, we focus on young adults and provide the first comprehensive and comparative assessment of the hypertension attributable CVDs burden, in terms of its mortality and years of living with disability (YLD) from 1990 to 2019, stratified by location, sex, and development status.
RESULTS: Globally in 2019, the death and YLD numbers caused by hypertension-related CVDs were 640 239 and 2 717 474 in young adults, marking a 43.0 and 86.6% increase from 1990, respectively. The corresponding mortality rate dropped by 10.5%, whereas the YLD rate increased by 16.8% during the same period. V-shaped association between CVDs burden and social development status was observed. The largest burden and the most pronounced increase were borne by middle-income countries, while high-income countries had the lowest death/YLD rate with a quicker annual decline. Men largely outpaced women in hypertension attributable CVDs mortality. Ischemic heart disease and stroke were the leading cause for death and YLD burden, correspondingly.
CONCLUSIONS: Hypertension attributable CVDs burden in young adults has greatly increased from 1990 to 2019, with considerably spatiotemporal and sexual heterogeneity. The largest burden was borne by middle-income countries, especially by men. Establishment of geographically and sexually tailored strategies were needed to prevent hypertension-related CVDs in young adults.
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34269332     DOI: 10.1097/HJH.0000000000002958

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

Review 1.  Antenatal Programming of Hypertension: Paradigms, Paradoxes, and How We Move Forward.

Authors:  Andrew M South; Norrina B Allen
Journal:  Curr Hypertens Rep       Date:  2022-10-13       Impact factor: 4.592

2.  Prevalence, Awareness, Treatment, and Control of Hypertension among Adult Residents of Tehran: The Tehran Cohort Study.

Authors:  Alireza Oraii; Akbar Shafiee; Arash Jalali; Farshid Alaeddini; Soheil Saadat; Saeed Sadeghian; Hamidreza Poorhosseini; Mohamamdali Boroumand; Abbasali Karimi; Oscar H Franco
Journal:  Glob Heart       Date:  2022-05-11

3.  Epidemiology of arterial hypertension in Tunisia: Hammam Sousse Sahloul Heart Study (HSHS).

Authors:  Aicha Hamoudi; Asma Ben Abdelaziz; Sarra Melki; Donia Ben Hassine; Nabila Ben Rejeb; Asma Omezzine; Ali Bouslama; Ahmed Ben Abdelaziz
Journal:  Tunis Med       Date:  2022 fevrier

4.  Hearing Problems in Indonesia: Attention to Hypertensive Adults.

Authors:  Melysa Fitriana; Chyi-Huey Bai
Journal:  Int J Environ Res Public Health       Date:  2022-07-28       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.